Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 79 of 108, showing 5 Applications out of 536 total, starting on record 391, ending on 395

# Protocol No Study Title Investigator(s) & Site(s)

391.

ECCT/16/12/02   Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis:
    Rifapentine-containing treatment shortening regimens for pulmonary tuberculosis: A randomized, open-label, controlled phase 3 clinical trial.   
Principal Investigator(s)
1. ISAAC TSIKHUTSU
Site(s) in Kenya
KEMRI/WRP, KERICHO
 
View

392.

ECCT/16/12/01   The Partners Scale-Up Project
    Animplementation project to scale-up delivery of antiretroviral-based HIV-1 prevention amongKenyan HIV-1 serodiscordant couples.   
Principal Investigator(s)
1. Prof. Elizabeth Ann Bukusi
Site(s) in Kenya
1. KISUMU SITE (Kisumu county)
2. Thika Site (Kiambu county)
 
View

393.

ECCT/16/12/03   The Partners Scale-Up Project
    An implementation project to scale-up delivery of antiretroviral-based HIV-1 prevention among Kenyan HIV-1 serodiscordant couples   
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. Thika Level 5 Hospital, Ruiru Sub-County Hospital, Kiambu County Hospital, Kikuyu PCEA Hospital (Kiambu county)
2. Coptic Hospital, Mbagathi Hospital, St. Mary\'s Hospital, Pumwani Maternity Hospital (Nairobi City county)
3. Nyeri PGH, Karatina Sub-County Hospital, (Nyeri county)
4. Kerugoya County Hospital (Kirinyaga county)
5. Murang\'a County Hospital (Murang\'a county)
 
View

394.

ECCT/17/03/03   FLACSAM
    First Line Antimicrobials in Children with Complicated Severe Acute Malnutrition   
Principal Investigator(s)
1. James Berkley
Site(s) in Kenya
1. Kilifi County Hospital (Kilifi county)
2. Coast General Hospital (Mombasa county)
3. Mbagathi Hospital (Nairobi City county)
 
View

395.

ECCT/16/11/04   RV456
    A Randomized, Observer-blind, Placebo-controlled, Two part, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Two Prime-boost Regimens of the Candidate Prophylactic Vaccines for Ebola Ad26.ZEBOV and MVA-BN-Filo   
Principal Investigator(s)
1. JANET OYIEKO
Site(s) in Kenya
KOMBEWA CLINICAL RESEARCH CENTRE
 
View